AI in Protein Engineering Market by AI Tools (Generative, Protein Language, Structure-Based), Application (Binder, De Novo, Enzyme Engineering), Protein Type (Antibody, Peptide), Process (Discovery, Design), End User (CRO, Pharma) – Global Forecast to 2031

Market Size
$1.44B
MARKET SIZE, 2026
Projected Market Size
$3.82B
MARKET SIZE, 2031
CAGR
21.6%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

AI IN PROTEIN ENGINEERING MARKET SIZE, SHARE & GROWTH SNAPSHOT

ai-in-protein-engineering-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global AI in protein engineering market is projected to grow from USD 1.44 billion in 2026 to USD 3.82 billion by 2031, at a CAGR of 21.6% during the forecast period. The market was valued at USD 1.21 billion in 2025. The market is driven by the increasing adoption of AI-powered protein design and optimization technologies to accelerate protein discovery, reduce experimental iterations, and improve engineering outcomes. The growing use of generative AI, protein language models, machine learning, and structure-based AI, along with the need to optimize protein sequences, enhance stability and affinity, and identify promising candidates, is accelerating the adoption of AI-enabled protein engineering platforms.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 1.21 Billion
    Current Market Size (2026): USD 1.44 Billion
    Forecast Market Size (2031): USD 3.82 Billion
    CAGR (2026–2031): 21.6%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America dominates the AI in protein engineering market, with a share of 48.6% in 2025.
    Offering Leader: Software/platforms dominate the market with a share of 75.4% in 2025.
    Technology Leader: Protein language models are expected to register the highest CAGR during the forecast period.
    Application Leader: De novo protein design segment dominated the AI in protein engineering market in 2025.
    Protein Type Leader: Miniproteins segment is expected to register the highest CAGR of 23.7% during the forecast period.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Schrodinger, Inc., XtalPi, and Dassault Systèmes were identified as some of the star players in the AI in protein engineering market (global), given their strong market share and product footprint.
    Companies such as Arzeda Corporation and Evozyne, among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The AI in protein engineering market is fueled by the demand for faster, more precise, and scalable protein discovery and optimization through advanced computational approaches. The growing adoption of generative AI, protein language models, machine learning, and structure-based AI, combined with the increasing complexity of biologics and next-generation protein therapeutics, is encouraging pharmaceutical and biotechnology companies, CROs, and research organizations to implement AI-enabled protein engineering tools to reduce experimental iterations, accelerate candidate development, and improve the probability of identifying high-performing proteins.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The AI in protein engineering market has undergone a significant transformation, shifting from traditional computational protein modeling and sequence-analysis tools to AI-driven, generative, and integrated protein engineering platforms. Vendors are moving beyond conventional structure prediction and molecular modeling toward advanced capabilities such as protein language models, generative AI, de novo protein design, AI-based antibody and enzyme optimization, and automated design-build-test-learn workflows. As demand for faster protein discovery grows among pharmaceutical and biotechnology companies, CROs, academic researchers, and industrial biotechnology organizations, these technologies are reshaping protein engineering workflows. As protein development becomes more complex, particularly for next-generation biologics, multispecific proteins, engineered enzymes, and novel protein therapeutics, AI-enabled platforms are increasingly important for exploring large sequence spaces, improving candidate quality, reducing experimental iterations, and accelerating the transition from computational design to experimental validation.

ai-in-protein-engineering-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing adoption of generative AI and protein foundation models
  • Rising demand for next-generation biologics and engineered proteins
RESTRAINTS
Impact
Level
  • Limited availability of high-quality, experimentally validated protein data
  • High cost and complexity of experimental validation
OPPORTUNITIES
Impact
Level
  • Expansion of AI-designed de novo proteins
  • Growth of AI-enabled antibody discovery and optimization
CHALLENGES
Impact
Level
  • Biosecurity and biosafety concerns
  • Lack of standardized benchmarking across AI protein-engineering platforms

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing adoption of generative AI and protein foundation models

The growing adoption of generative AI and protein foundation models is driving the AI in protein engineering market by enabling the generation, prediction, and optimization of protein sequences at scales beyond conventional computational approaches. These models can learn from large protein sequence and structural datasets to identify sequence-function relationships and generate novel proteins with desired characteristics. Their growing application in de novo protein design, antibody engineering, enzyme optimization, and protein stability prediction is reducing reliance on trial-and-error approaches and accelerating the design-to-validation cycle.

Restraint: Limited availability of high-quality, experimentally validated protein data

The limited availability of high-quality, standardized, and experimentally validated protein sequence-function data restrains market growth by affecting the training and reliability of AI models. Although large protein sequence databases are expanding rapidly, much of the available data lacks detailed experimental measurements for properties such as activity, stability, binding affinity, and specificity. Differences in experimental protocols and incomplete annotations further reduce data consistency, making it difficult to train models that reliably generalize across proteins and biological contexts.

Opportunity: Expansion of AI-designed de novo proteins

The expansion of AI-designed de novo proteins presents a significant opportunity as generative models enable researchers to create proteins that do not exist naturally and tailor them for specific therapeutic, industrial, and research applications. AI can explore vast sequence and structural spaces to design proteins with targeted binding, catalytic activity, stability, and specificity, opening opportunities across next-generation biologics, enzymes, protein binders, and synthetic biology. Increasing integration of AI design with automated synthesis and high-throughput screening is further creating opportunities for scalable protein engineering.

Challenge: Biosecurity and biosafety concerns

Biosecurity and biosafety concerns represent a growing challenge as AI systems become capable of designing novel proteins with potentially unintended biological properties. The ability to generate or modify proteins at scale raises concerns regarding the misuse of AI-designed sequences, including the potential creation of harmful biological agents or proteins with undesirable functions. These concerns are increasing the need for sequence screening, responsible AI frameworks, access controls, experimental safeguards, and regulatory oversight, which may add complexity to the development and deployment of AI-enabled protein engineering platforms.

AI IN PROTEIN ENGINEERING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
AI/physics-based protein design and optimization Faster protein optimization, reduced experimental screening, improved candidate quality, and lower protein engineering costs
company logo
AI-driven protein/peptide design and high-throughput screening Faster candidate discovery; improved screening efficiency
company logo
AI-driven protein structure prediction and molecular simulation Accelerates protein structure analysis and enables computational evaluation of protein behavior and interactions
company logo
AI for protein binder and antibody design Supports computational generation and optimization of protein binders and antibody candidates with desired properties
company logo
Generative AI, de novo protein design & design-build-test workflows Faster protein discovery; fewer experimental iterations

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The AI in protein engineering market ecosystem consists of leading providers such as Schrödinger, Inc., XtalPi, Dassault Systèmes, NVIDIA Corporation, Generate: Biomedicines, Absci Corp., and Insilico Medicine, which offer technologies including generative AI, protein language models, de novo protein design, structure-based modeling, antibody engineering, and protein optimization solutions. Emerging companies such as Chai Discovery, EvolutionaryScale, Profluent, BigHat Bio, Cradle, and Latent Labs are advancing AI-driven protein design, sequence generation, and optimization capabilities. Cloud and computational infrastructure providers such as AWS, Microsoft Azure, and Google Cloud support the high-performance computing and scalable environments required for AI-based protein engineering. End users, including pharmaceutical and biotechnology companies, CROs, academic research institutes, and industrial biotechnology companies, leverage these platforms to accelerate protein discovery, optimize candidates, reduce experimental iterations, and improve R&D productivity.

ai-in-protein-engineering-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

ai-in-protein-engineering-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

AI in Protein Engineering Market, By Offering

In 2025, the software/platforms segment accounted for the largest share of the AI in protein engineering market, as AI-powered platforms provide the core infrastructure for protein discovery, design, optimization, and characterization. These solutions enable researchers to analyze protein sequences and structures, generate novel proteins, predict functional properties, and prioritize candidates before experimental validation. The growing adoption of generative AI, protein language models, machine learning, and structure-based AI, along with increasing demand for de novo protein design and AI-driven antibody and enzyme engineering, has further strengthened platform adoption. Additionally, integration with high-throughput experimentation, automated design-build-test workflows, cloud computing, and large-scale protein datasets is driving organizations to invest in advanced AI protein engineering platforms to accelerate discovery, reduce experimental iterations, and improve R&D productivity.

AI in Protein Engineering Market, By AI Tool

By AI tool, the Generative AI segment accounted for the largest share of the AI in protein engineering market in 2025, securing the highest share of market revenue compared with other AI tools. Generative AI's leading position is primarily driven by its growing use in de novo protein design, protein sequence generation, antibody engineering, enzyme optimization, and the development of next-generation biologics. Generative AI enables researchers to explore vast protein sequence spaces and design novel proteins with desired structural and functional properties, reducing dependence on conventional trial-and-error approaches. Increasing availability of large protein datasets, advances in foundation models, and integration with automated high-throughput experimentation are further strengthening adoption of generative AI for faster protein discovery, optimization, and validation.

AI in Protein Engineering Market, By Application

By application, the antibody discovery and optimization segment accounted for the largest share of the AI in protein engineering market in 2025, securing the highest share of market revenue compared with other applications. This segment's leading position is primarily driven by the widespread use of AI in antibody discovery, affinity optimization, specificity and cross-reactivity assessment, developability optimization, and bispecific and multispecific antibody engineering. AI technologies enable researchers to screen large antibody sequence spaces, predict antibody–antigen interactions, identify promising candidates, and optimize key properties before experimental testing. The increasing development of next-generation antibodies and targeted biologics, coupled with growing adoption of generative AI and protein language models, is further strengthening demand for AI-enabled antibody engineering solutions.

AI in Protein Engineering Market, By Protein Type

In 2025, the antibodies segment accounted for the largest share of the AI in protein engineering market by protein type. This leading position stems from the extensive use of AI across antibody development, including sequence generation, candidate discovery, affinity and specificity optimization, and developability assessment. The expanding pipeline of antibody-based therapeutics, particularly bispecific and multispecific antibodies, is increasing demand for AI-enabled approaches that can efficiently evaluate and optimize large numbers of protein variants. Furthermore, advances in generative AI and protein language models enable faster, more precise antibody engineering, improving candidate quality and accelerating experimental validation.

AI in Protein Engineering Market, By Protein Engineering Process

In 2025, the protein design segment held the largest share of the AI in protein engineering market by process. The dominance of this segment can be attributed to the increasing application of AI for designing novel protein sequences and structures with predefined functional characteristics. AI-enabled design tools allow researchers to evaluate extensive sequence and structural possibilities, identify promising candidates, and optimize desired properties before laboratory testing. The growing focus on de novo protein design, therapeutic proteins, enzymes, and other next-generation biologics is further expanding the use of AI during the design stage. In addition, advancements in generative AI, protein language models, and structure-based approaches are improving the efficiency and precision of protein design, supporting faster progression toward experimental validation.

AI in Protein Engineering Market, By End User

The pharmaceutical & biotechnology companies segment held the largest share of the AI in protein engineering market by end user in 2025, owing to the extensive adoption of AI technologies across protein discovery and development activities. These companies are increasingly using AI-powered platforms for de novo protein design, antibody discovery and optimization, enzyme engineering, protein stability assessment, and developability optimization to improve R&D efficiency. The growing complexity of biologic pipelines and the need to accelerate candidate identification are further driving investments in AI-enabled protein engineering solutions. In addition, integrating AI with high-throughput screening, automated experimentation, and large-scale protein datasets enables pharmaceutical and biotechnology companies to reduce experimental iterations and accelerate the development of novel protein therapeutics.

REGION

Asia Pacific to register the highest CAGR during the forecast period

The Asia Pacific region is the fastest-growing market for AI in protein engineering, supported by increasing pharmaceutical and biotechnology R&D activities, rising adoption of AI-driven protein design and optimization technologies, and growing investments in life sciences innovation. Furthermore, expanding capabilities in biopharmaceutical development, computational biology, and high-throughput experimentation, along with supportive government initiatives and improving research infrastructure, are driving the adoption of AI-enabled protein engineering platforms across the region. The increasing focus on accelerating protein discovery, developing next-generation biologics, and reducing experimental iterations is further contributing to market growth.

ai-in-protein-engineering-market Region

AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX

Schrödinger, Inc. (Star) stands out with strong market positioning and a comprehensive AI-driven protein engineering portfolio, supported by its physics-based computational platform and AI-enabled solutions for protein structure prediction, molecular modeling, protein design, and biologics optimization. Its broad capabilities across computational protein engineering, integrated modeling workflows, and collaborations with pharmaceutical and biotechnology companies strengthen its position across the protein discovery and development lifecycle. Isomorphic Labs (Emerging Leader) has gained recognition through its AI-driven approach to protein structure and drug design, supported by technology originating from DeepMind's AlphaFold research and strategic collaborations with major pharmaceutical companies, including Eli Lilly and Novartis. While Schrodinger, Inc. leads through its established computational platform, broad protein engineering capabilities, integrated AI and physics-based workflows, and commercial partnerships, Isomorphic Labs demonstrates strong potential to move toward the leaders' quadrant as demand for AI-powered protein design, structure-based modeling, and accelerated biologics discovery continues to grow.

ai-in-protein-engineering-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 1.21 BN
Market Forecast in 2026 (Value) USD 1.44 BN
Market Forecast in 2031 (Value) USD 3.82 BN
Growth Rate CAGR of 21.6% from 2026–2031
Years Considered 2024–2031
Base Year 2025
Forecast Period 2026–2031
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Software/Platforms
    • Services
  • By AI tool:
    • Machine Learning & Deep Learning
    • Protein Language Models
    • Generative AI
    • Structure-based AI
    • Other Tools
  • By Application:
    • Next-generation Biologics
    • Molecular Glues
    • Data Generation
    • Antibody Discovery & Optimization
    • Enzyme Engineering
    • De Novo Protein Design
    • Protein Stability & Developability Optimization
    • Other Applications
  • By Protein Type:
    • Antibodies
    • Enzymes
    • Cytokines & Growth Factors
    • Peptides
    • Fusion Proteins
    • Miniproteins
    • Other Proteins
  • By Protein Engineering Process:
    • Protein Discovery
    • Protein Design
    • Protein Optimization
    • Protein Characterization
    • Experimental Validation
  • By End User:
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Contract Research Organizations
    • Industrial Biotechnology Companies
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: AI IN PROTEIN ENGINEERING MARKET REPORT CONTENT GUIDE

ai-in-protein-engineering-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Local Competitive Landscape Profiling of leading AI protein engineering players covering AI capabilities, applications, platforms, protein types, partnerships, and offerings. Enables competitive benchmarking, gap identification, and differentiation.
Regional Market Entry Strategy Assessment of AI adoption, pharma/biotech R&D, research infrastructure, talent, funding, and startup ecosystems across key regions. Supports market prioritization, localization, and investment decisions.
Local Risk & Opportunity Assessment Evaluation of data availability, validation requirements, talent gaps, AI adoption barriers, biosecurity considerations, and opportunities across key protein engineering applications. Supports risk mitigation and identification of growth opportunities.
Technology Adoption Mapping adoption of generative AI, protein language models, ML/DL, structure-based AI, de novo protein design, antibody engineering, enzyme engineering, and automated workflows. Guides technology strategy, product development, and alignment with customer needs.

RECENT DEVELOPMENTS

  • June 2026 : Cradle partnered with Lundbeck to deploy its generative AI protein design platform for two antibody programs targeting CNS diseases, enabling an end-to-end, AI-guided protein engineering workflow that improves antibody candidates and reduces wet-lab iterations.
  • December 2025 : XtalPi partnered with Gan & Lee Pharmaceuticals to advance AI-driven peptide drug discovery for metabolic diseases, leveraging its PepiX platform for generative design, stability optimization, developability prediction, and high-throughput screening
  • December 2024 : AI Proteins partnered with Bristol Myers Squibb to discover and develop novel AI-designed miniprotein therapeutics, leveraging its AI-driven platform for de novo protein design and optimization. The collaboration covers two undisclosed targets, with potential development, regulatory, and commercial milestone payments of up to USD 400 million, plus royalties.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
37
2
EXECUTIVE SUMMARY
 
 
 
 
 
43
3
PREMIUM INSIGHTS
 
 
 
 
 
50
4
MARKET OVERVIEW
Generative AI and protein models drive next-gen biologics amid biosecurity and benchmarking challenges.
 
 
 
 
 
53
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING ADOPTION OF GENERATIVE AI AND PROTEIN FOUNDATION MODELS
 
 
 
 
 
 
4.2.1.2
RISING DEMAND FOR NEXT-GENERATION BIOLOGICS AND ENGINEERED PROTEINS
 
 
 
 
 
 
4.2.1.3
INCREASING AVAILABILITY OF PROTEIN SEQUENCE, STRUCTURE, AND EXPERIMENTAL DATASETS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
 
LIMITED AVAILABILITY OF HIGH-QUALITY EXPERIMENTALLY
 
 
 
 
 
 
4.2.2.2
HIGH COST AND COMPLEXITY OF EXPERIMENTAL VALIDATION
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANSION OF AI-DESIGNED DE NOVO PROTEINS
 
 
 
 
 
 
4.2.3.2
GROWTH OF AI-ENABLED ANTIBODY DISCOVERY AND OPTIMIZATION
 
 
 
 
 
 
4.2.3.3
INCREASING DEMAND FOR PROPRIETARY PROTEIN-ENGINEERING DATASETS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
BIOSECURITY AND BIOSAFETY CONCERNS
 
 
 
 
 
 
4.2.4.2
LACK OF STANDARDIZED BENCHMARKING ACROSS AI PROTEIN-ENGINEERING PLATFORMS
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
AI-driven protein engineering revolutionizes healthcare IT, reshaping competitive dynamics and investment landscapes globally.
 
 
 
 
 
62
 
5.1
INDUSTRY TRENDS IN GLOBAL AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
5.2
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.2.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.2.2
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.2.3
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.2.4
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.2.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.3
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.3.1
INTRODUCTION
 
 
 
 
 
 
5.3.2
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.3.3
TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
RESEARCH & PRODUCT DEVELOPMENT
 
 
 
 
 
 
5.4.2
DATA INPUTS & COMPUTATIONAL INFRASTRUCTURE
 
 
 
 
 
 
5.4.3
AI MODEL & PLATFORM DEVELOPMENT
 
 
 
 
 
 
5.4.4
PLATFORM DEPLOYMENT & INTEGRATION
 
 
 
 
 
 
5.4.5
MARKETING AND SALES
 
 
 
 
 
 
5.4.6
POST-SALE SERVICES
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
 
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,
 
 
 
 
 
 
 
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET,
 
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
 
 
5.11.5
IMPACT ON END USERS
 
 
 
 
 
 
 
5.11.5.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.2
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.11.5.3
CONTRACT RESEARCH ORGANIZATIONS
 
 
 
 
 
 
5.11.5.4
INDUSTRIAL BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
5.11.5.5
OTHER END USERS
 
 
 
 
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
 
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
GENERATIVE AI FOR PROTEIN DESIGN
 
 
 
 
 
 
6.1.2
PROTEIN LANGUAGE MODELS (PLMS)
 
 
 
 
 
 
6.1.3
STRUCTURE-BASED AI FOR PROTEIN ENGINEERING
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
HIGH-PERFORMANCE COMPUTING (HPC) AND CLOUD COMPUTING
 
 
 
 
 
 
6.2.2
LABORATORY AUTOMATION AND HIGH-THROUGHPUT SCREENING
 
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
COMPUTATIONAL CHEMISTRY AND MOLECULAR SIMULATION
 
 
 
 
 
 
6.3.2
BIOINFORMATICS AND BIOLOGICAL DATA ANALYTICS
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
PATENT PUBLICATION TRENDS FOR AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
6.5.2
INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
 
6.6.1
AI-ENABLED INTELLIGENT PROTEIN DESIGN AND PREDICTION
 
 
 
 
 
 
 
AI-DRIVEN AUTOMATED PROTEIN ENGINEERING AND DESIGN-BUILD-
 
 
 
 
 
 
6.6.3
AI-ENABLED PERSONALIZED AND FUNCTION-SPECIFIC PROTEIN ENGINEERING
 
 
 
 
7
REGULATORY LANDSCAPE
Navigate complex global regulations with region-specific insights and compliance strategies.
 
 
 
 
 
88
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
 
7.1.2.1
NORTH AMERICA
 
 
 
 
 
 
7.1.2.2
EUROPE
 
 
 
 
 
 
7.1.2.3
ASIA PACIFIC
 
 
 
 
 
 
7.1.2.4
LATIN AMERICA
 
 
 
 
 
 
7.1.2.5
MIDDLE EAST & AFRICA
 
 
 
 
 
7.1.3
INDUSTRY STANDARDS
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Discover unmet needs and decision influencers shaping AI-driven protein engineering market opportunities.
 
 
 
 
 
99
 
8.1
INTRODUCTION
 
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
 
8.5.1
UNMET NEEDS
 
 
 
 
 
 
8.5.2
END USER EXPECTATIONS
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
 
9
AI IN PROTEIN ENGINEERING MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 10 Data Tables
 
 
 
 
 
106
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
SOFTWARE/PLATFORMS
 
 
 
 
 
 
 
9.2.1
NICHE POINT SOLUTIONS
 
 
 
 
 
 
 
 
SPECIALIZED AI PLATFORMS EXPAND PROTEIN ENGINEERING BEYOND
 
 
 
 
 
9.2.2
END-TO-END SOLUTIONS
 
 
 
 
 
 
 
9.2.2.1
INTEGRATED AI PLATFORMS ENABLE MULTI-STAGE PROTEIN ENGINEERING AND ACCELERATE CANDIDATE DEVELOPMENT
 
 
 
 
9.3
SERVICES
 
 
 
 
 
 
 
9.3.1
CONSULTING & ADVISORY SERVICES
 
 
 
 
 
 
 
9.3.1.1
INCREASING COMPLEXITY OF AI ADOPTION CREATES DEMAND FOR PROTEIN ENGINEERING STRATEGY AND TECHNICAL EXPERTISE
 
 
 
 
 
9.3.2
IMPLEMENTATION & INTEGRATION SERVICES
 
 
 
 
 
 
 
 
INTEGRATION COMPLEXITY AND DATA COMPATIBILITY SHAPE ADOPTION OF
 
 
 
 
 
9.3.3
TRAINING & SUPPORT SERVICES
 
 
 
 
 
 
 
9.3.3.1
SPECIALIZED SKILLS GAPS AND EVOLVING AI TECHNOLOGIES SUSTAIN DEMAND FOR TRAINING & SUPPORT
 
 
 
10
AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
 
 
 
 
 
116
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
MACHINE LEARNING & DEEP LEARNING
 
 
 
 
 
 
 
10.2.1
FOUNDATIONAL NEURAL ARCHITECTURES UNDERPIN MODERN PROTEIN ENGINEERING WORKFLOWS
 
 
 
 
 
10.3
PROTEIN LANGUAGE MODELS
 
 
 
 
 
 
 
10.3.1
EVOLUTION-SCALE SEQUENCE MODELS ENABLE PREDICTION AND GENERATION WITHOUT STRUCTURAL INPUTS
 
 
 
 
 
10.4
GENERATIVE AI
 
 
 
 
 
 
 
10.4.1
GENERATIVE MODELS MOVE ANTIBODY AND BINDER DESIGN FROM SCREENING TO PROGRAMMABLE DESIGN
 
 
 
 
 
10.5
STRUCTURE-BASED AI
 
 
 
 
 
 
 
10.5.1
ACCURATE COMPLEX PREDICTION SUPPORTS EPITOPE-SPECIFIC DESIGN AND AFFINITY ESTIMATION
 
 
 
 
 
10.6
OTHER TOOLS
 
 
 
 
 
 
 
10.6.1
ACTIVE LEARNING, BAYESIAN OPTIMIZATION, AND LAB-IN-THE-LOOP PLATFORMS COMPLEMENT CORE MODEL CLASSES
 
 
 
 
11
AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 22 Data Tables
 
 
 
 
 
123
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
NEXT-GENERATION BIOLOGICS
 
 
 
 
 
 
 
11.2.1
THERAPEUTIC PROTEIN ENGINEERING
 
 
 
 
 
 
 
11.2.1.1
AI-OPTIMIZED ANTIBODIES AND ENGINEERED PROTEINS MOVE INTO LATE-STAGE DEVELOPMENT
 
 
 
 
 
11.2.2
MULTISPECIFIC & BISPECIFIC PROTEIN ENGINEERING
 
 
 
 
 
 
 
11.2.2.1
DUAL-TARGETING FORMATS ATTRACT RECORD LICENSING INVESTMENT AS ENGINEERING PLATFORMS MATURE
 
 
 
 
 
11.2.3
CYTOKINE & GROWTH FACTOR ENGINEERING
 
 
 
 
 
 
 
11.2.3.1
REDESIGNED CYTOKINES AIM TO SEPARATE THERAPEUTIC BENEFIT FROM SYSTEMIC TOXICITY
 
 
 
 
 
11.2.4
PROTEIN BINDER ENGINEERING
 
 
 
 
 
 
 
11.2.4.1
DE NOVO BINDER DESIGN REACHES DOUBLE-DIGIT TO NEAR-COMPLETE EXPERIMENTAL HIT RATES
 
 
 
 
 
11.2.5
OTHER NEXT-GENERATION BIOLOGICS
 
 
 
 
 
 
 
11.2.5.1
ANTIBODY-DRUG CONJUGATES, SCAFFOLD FUSIONS, AND NOVEL FORMATS BROADEN ENGINEERING TOOLKITS
 
 
 
 
11.3
MOLECULAR GLUES
 
 
 
 
 
 
11.4
DATA GENERATION
 
 
 
 
 
 
11.5
ANTIBODY DISCOVERY & OPTIMIZATION
 
 
 
 
 
 
 
11.5.1
ANTIBODY DISCOVERY
 
 
 
 
 
 
 
11.5.1.1
GENERATIVE DESIGN REDUCES DEPENDENCE ON IMMUNIZATION AND LIBRARY SCREENING
 
 
 
 
 
11.5.2
ANTIBODY AFFINITY OPTIMIZATION
 
 
 
 
 
 
 
11.5.2.1
COMPUTATIONAL LEAD OPTIMIZATION IMPROVES POTENCY AND DOSING CONVENIENCE
 
 
 
 
 
11.5.3
ANTIBODY SPECIFICITY & CROSS-REACTIVITY OPTIMIZATION
 
 
 
 
 
 
 
11.5.3.1
ATOMIC-LEVEL DESIGN ENABLES SELECTIVE BINDING AND CONTROLLED SPECIES CROSS-REACTIVITY
 
 
 
 
 
11.5.4
ANTIBODY DEVELOPABILITY OPTIMIZATION
 
 
 
 
 
 
 
11.5.4.1
EARLY DEVELOPABILITY SCREENING REDUCES LATE-STAGE ATTRITION RISK
 
 
 
 
 
11.5.5
BISPECIFIC & MULTISPECIFIC ANTIBODY ENGINEERING
 
 
 
 
 
 
 
11.5.5.1
MATURING FORMATS AND DESIGN PLATFORMS EXTEND BEYOND ONCOLOGY T-CELL ENGAGERS
 
 
 
 
 
11.5.6
OTHER ANTIBODY ENGINEERING
 
 
 
 
 
 
 
11.5.6.1
FC MODIFICATION, HALF-LIFE EXTENSION, AND DELIVERY FORMATS BROADEN ANTIBODY DIFFERENTIATION
 
 
 
 
11.6
ENZYME ENGINEERING
 
 
 
 
 
 
11.7
DE NOVO PROTEIN DESIGN
 
 
 
 
 
 
11.8
PROTEIN STABILITY & DEVELOPABILITY OPTIMIZATION
 
 
 
 
 
 
11.9
OTHER APPLICATIONS
 
 
 
 
 
12
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables
 
 
 
 
 
144
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
ANTIBODIES
 
 
 
 
 
 
 
12.2.1
AI-DRIVEN ANTIBODY DESIGN AND OPTIMIZATION ACCELERATE NEXT-GENERATION BIOLOGICS DEVELOPMENT
 
 
 
 
 
12.3
ENZYMES
 
 
 
 
 
 
 
12.3.1
AI-POWERED ENZYME ENGINEERING EXPANDS APPLICATIONS ACROSS INDUSTRIAL BIOCATALYSIS
 
 
 
 
 
12.4
CYTOKINES & GROWTH FACTORS
 
 
 
 
 
 
 
12.4.1
ADVANCING PRECISION ENGINEERING OF CYTOKINES AND GROWTH FACTORS
 
 
 
 
 
12.5
PEPTIDES
 
 
 
 
 
 
 
12.5.1
AI ADDRESSES COMPLEXITY IN PEPTIDE SEQUENCE DESIGN AND FUNCTIONAL OPTIMIZATION
 
 
 
 
 
12.6
FUSION PROTEINS
 
 
 
 
 
 
 
12.6.1
AI IMPROVES MULTI-DOMAIN DESIGN OF FUSION PROTEINS
 
 
 
 
 
12.7
MINIPROTEIN
 
 
 
 
 
 
 
12.7.1
DE NOVO MINIPROTEIN DESIGN OPENS NEW OPPORTUNITIES FOR PRECISION BIOLOGICS
 
 
 
 
 
12.8
OTHER PROTEINS
 
 
 
 
 
 
 
12.8.1
EMERGING PROTEIN MODALITIES CREATE NEW OPPORTUNITIES FOR AI-ENABLED ENGINEERING
 
 
 
 
13
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
 
 
 
 
 
153
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
PROTEIN DISCOVERY
 
 
 
 
 
 
 
13.2.1
EXPANDING SEQUENCE AND STRUCTURE DATABASES ACCELERATE TARGET AND STARTING-POINT IDENTIFICATION
 
 
 
 
 
13.3
PROTEIN DESIGN
 
 
 
 
 
 
 
13.3.1
OPEN GENERATIVE MODELS MOVE DE NOVO DESIGN FROM PROOF OF CONCEPT TO BROAD EXPERIMENTAL VALIDATION
 
 
 
 
 
13.4
PROTEIN OPTIMIZATION
 
 
 
 
 
 
 
13.4.1
MACHINE LEARNING-GUIDED OPTIMIZATION IMPROVES AFFINITY, STABILITY, AND MANUFACTURABILITY ACROSS ITERATIVE CYCLES
 
 
 
 
 
13.5
PROTEIN CHARACTERIZATION
 
 
 
 
 
 
 
13.5.1
HIGHER-RESOLUTION STRUCTURAL AND BIOPHYSICAL ANALYSIS ANCHORS COMPUTATIONAL PREDICTIONS IN EXPERIMENTAL REALITY
 
 
 
 
 
13.6
EXPERIMENTAL VALIDATION
 
 
 
 
 
 
 
13.6.1
CLOUD LABS, PUBLIC COMPETITIONS, AND LAB-IN-THE-LOOP PLATFORMS SCALE WET-LAB TESTING
 
 
 
 
14
AI IN PROTEIN ENGINEERING MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
 
 
 
 
 
160
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
14.2.1
HIGH R&D INVESTMENTS AND GROWING AI INTEGRATION ACCELERATE PROTEIN ENGINEERING ADOPTION
 
 
 
 
 
14.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
 
 
ADVANCING PROTEIN SCIENCE THROUGH AI-ENABLED RESEARCH
 
 
 
 
 
14.4
CONTRACT RESEARCH ORGANIZATIONS
 
 
 
 
 
 
 
 
AI HELPS CROS DIFFERENTIATE PROTEIN ENGINEERING SERVICES
 
 
 
 
 
14.5
INDUSTRIAL BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
 
AI-DRIVEN BIOCATALYST DEVELOPMENT ACCELERATES
 
 
 
 
 
14.6
OTHER END USERS
 
 
 
 
 
 
 
14.6.1
EXPANSION OF AI-ENABLED PROTEIN ENGINEERING ACROSS DIVERSE APPLICATIONS TO BOOST SEGMENT
 
 
 
 
15
AI IN PROTEIN ENGINEERING MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 17 Countries | 287 Data Tables.
 
 
 
 
 
167
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
NORTH AMERICA
 
 
 
 
 
 
 
15.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
 
15.2.2
US
 
 
 
 
 
 
 
 
AI-DRIVEN PROTEIN DESIGN AND STRONG BIOPHARMACEUTICAL
 
 
 
 
 
15.2.3
CANADA
 
 
 
 
 
 
 
15.2.3.1
GOVERNMENT SUPPORT FOR AI INNOVATION AND BIOMANUFACTURING STRENGTHENS MARKET GROWTH
 
 
 
 
15.3
EUROPE
 
 
 
 
 
 
 
15.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
 
15.3.2
GERMANY
 
 
 
 
 
 
 
 
STRONG PHARMACEUTICAL RESEARCH BASE AND AI INNOVATION
 
 
 
 
 
15.3.3
FRANCE
 
 
 
 
 
 
 
15.3.3.1
BIOPHARMA INNOVATION AND RESEARCH COMMERCIALIZATION SUPPORT MARKET EXPANSION
 
 
 
 
 
15.3.4
UK
 
 
 
 
 
 
 
15.3.4.1
REGULATORY INNOVATION AND AI-DRIVEN DRUG DISCOVERY ACCELERATE ADOPTION
 
 
 
 
 
15.3.5
ITALY
 
 
 
 
 
 
 
15.3.5.1
PHARMACEUTICAL MANUFACTURING STRENGTH AND RESEARCH MODERNIZATION CREATE OPPORTUNITIES
 
 
 
 
 
15.3.6
SPAIN
 
 
 
 
 
 
 
15.3.6.1
STRONG PHARMACEUTICAL R&D AND BIOPHARMA ECOSYSTEM SUPPORT MARKET GROWTH
 
 
 
 
 
15.3.7
REST OF EUROPE
 
 
 
 
 
15.4
ASIA PACIFIC
 
 
 
 
 
 
 
15.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
 
15.4.2
CHINA
 
 
 
 
 
 
 
15.4.2.1
AI-DRIVEN PROTEIN ENGINEERING AND BIOLOGICS INNOVATION RESHAPE PHARMACEUTICAL DEVELOPMENT
 
 
 
 
 
15.4.3
JAPAN
 
 
 
 
 
 
 
15.4.3.1
DEMOGRAPHIC PRESSURES AND AI INNOVATION DRIVE PROTEIN ENGINEERING ADOPTION
 
 
 
 
 
15.4.4
INDIA
 
 
 
 
 
 
 
15.4.4.1
COST-EFFICIENT INNOVATION AND BIOTECHNOLOGY EXPANSION SUPPORT GROWTH
 
 
 
 
 
15.4.5
AUSTRALIA
 
 
 
 
 
 
 
15.4.5.1
TRANSLATIONAL RESEARCH ECOSYSTEM SUPPORTS AI-ENABLED PROTEIN ENGINEERING
 
 
 
 
 
15.4.6
SOUTH KOREA
 
 
 
 
 
 
 
 
BIOTECHNOLOGY EXPANSION AND AI INVESTMENTS SUPPORT
 
 
 
 
 
15.4.7
REST OF ASIA PACIFIC
 
 
 
 
 
15.5
LATIN AMERICA
 
 
 
 
 
 
 
15.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
 
15.5.2
BRAZIL
 
 
 
 
 
 
 
 
LEADING REGIONAL PHARMACEUTICAL RESEARCH ACTIVITY SUPPORTS
 
 
 
 
 
15.5.3
MEXICO
 
 
 
 
 
 
 
 
PHARMACEUTICAL MANUFACTURING BASE AND GROWING R&D
 
 
 
 
 
15.5.4
REST OF LATIN AMERICA
 
 
 
 
 
15.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
15.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
 
 
15.6.2
GCC COUNTRIES
 
 
 
 
 
 
 
15.6.2.1
HEALTHCARE TRANSFORMATION AND BIOTECHNOLOGY INVESTMENTS SUPPORT MARKET GROWTH
 
 
 
 
 
 
15.6.2.2
SAUDI ARABIA
 
 
 
 
 
 
 
 
15.6.2.2.1
VISION 2030 INVESTMENTS ACCELERATE BIOTECHNOLOGY AND AI-ENABLED PROTEIN ENGINEERING
 
 
 
 
15.6.2.3
UAE
 
 
 
 
 
 
 
 
15.6.2.3.1
HEALTHCARE INNOVATION AND BIOTECHNOLOGY INITIATIVES SUPPORT MARKET GROWTH
 
 
 
 
15.6.2.4
OTHER GCC COUNTRIES
 
 
 
 
 
15.6.3
SOUTH AFRICA
 
 
 
 
 
 
 
15.6.3.1
EXPANDING BIOTECHNOLOGY AND RESEARCH CAPABILITIES SUPPORT MARKET GROWTH
 
 
 
 
 
15.6.4
REST OF MIDDLE EAST & AFRICA
 
 
 
 
16
COMPETITIVE LANDSCAPE
Discover strategic insights and market dominance tactics of top players and emerging competitors.
 
 
 
 
 
316
 
16.1
OVERVIEW
 
 
 
 
 
 
16.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
 
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
 
 
 
 
 
16.3
REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
 
 
 
 
 
 
16.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
16.5
BRAND COMPARISON
 
 
 
 
 
 
 
16.6
VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
16.6.1
FINANCIAL METRICS
 
 
 
 
 
 
16.6.2
COMPANY VALUATION
 
 
 
 
 
16.7
COMPANY EVALUATION MATRIX, KEY PLAYERS (2025)
 
 
 
 
 
 
 
 
16.7.1
STARS
 
 
 
 
 
 
16.7.2
EMERGING LEADERS
 
 
 
 
 
 
16.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
16.7.4
PARTICIPANTS
 
 
 
 
 
 
16.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
16.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
16.7.5.2
REGION FOOTPRINT
 
 
 
 
 
 
16.7.5.3
OFFERING FOOTPRINT
 
 
 
 
 
 
16.7.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
16.7.5.5
AI TOOL FOOTPRINT
 
 
 
 
 
 
16.7.5.6
END USER FOOTPRINT
 
 
 
 
16.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
16.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
16.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
16.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
16.8.4
STARTING BLOCKS
 
 
 
 
 
 
16.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
16.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
16.8.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
16.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
16.9.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
 
 
 
 
 
 
16.9.2
DEALS
 
 
 
 
17
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
338
 
17.1
KEY PLAYERS
 
 
 
 
 
 
 
17.1.1
SCHRÖDINGER, INC.
 
 
 
 
 
 
 
17.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
17.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
17.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
17.1.1.3.1
PRODUCT ENHANCEMENTS
 
 
 
 
 
 
17.1.1.3.2
DEALS
 
 
 
 
17.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
17.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
17.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
17.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
17.1.2
XTALPI
 
 
 
 
 
 
17.1.3
DASSAULT SYSTÈMES
 
 
 
 
 
 
17.1.4
NVIDIA CORPORATION
 
 
 
 
 
 
17.1.5
GENERATE:BIOMEDICINES
 
 
 
 
 
 
17.1.6
ABSCI CORP.
 
 
 
 
 
 
17.1.7
INSILICO MEDICINE
 
 
 
 
 
 
17.1.8
CRADLE
 
 
 
 
 
 
17.1.9
A-ALPHA BIO, INC.
 
 
 
 
 
 
17.1.10
ISOMORPHIC LABS
 
 
 
 
 
 
17.1.11
CHAI DISCOVERY
 
 
 
 
 
 
17.1.12
EVOLUTIONARYSCALE (BIOHUB)
 
 
 
 
 
 
17.1.13
PROFLUENT
 
 
 
 
 
 
17.1.14
BIGHAT BIO
 
 
 
 
 
 
17.1.15
LATENT LABS
 
 
 
 
 
 
17.1.16
BASECAMP RESEARCH
 
 
 
 
 
 
17.1.17
NABLA BIO, INC.
 
 
 
 
 
 
17.1.18
EVOZYNE
 
 
 
 
 
 
17.1.19
LABGENIUS LIMITED
 
 
 
 
 
17.2
OTHER PLAYERS
 
 
 
 
 
 
 
17.2.1
ARZEDA CORPORATION
 
 
 
 
 
 
17.2.2
MENTEN AI
 
 
 
 
 
 
17.2.3
PROTEINQURE
 
 
 
 
 
 
17.2.4
OUTPACE BIO
 
 
 
 
 
 
17.2.5
AI PROTEINS
 
 
 
 
 
 
17.2.6
MONODBIO
 
 
 
 
 
 
17.2.7
BIOMATTER INC.
 
 
 
 
 
 
17.2.8
DIFFUSE BIO
 
 
 
 
18
RESEARCH METHODOLOGY
 
 
 
 
 
411
 
18.1
RESEARCH APPROACH
 
 
 
 
 
 
 
18.1.1
SECONDARY RESEARCH
 
 
 
 
 
 
 
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
18.1.2
PRIMARY RESEARCH
 
 
 
 
 
 
 
18.1.2.1
PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.2
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
18.1.2.3
BREAKDOWN OF PRIMARIES
 
 
 
 
 
 
18.1.2.4
INSIGHTS FROM PRIMARY EXPERTS
 
 
 
 
18.2
RESEARCH METHODOLOGY DESIGN
 
 
 
 
 
 
18.3
MARKET SIZE ESTIMATION
 
 
 
 
 
 
18.4
MARKET BREAKDOWN DATA TRIANGULATION
 
 
 
 
 
 
18.5
MARKET SHARE ESTIMATION
 
 
 
 
 
 
18.6
STUDY ASSUMPTIONS
 
 
 
 
 
 
18.7
RESEARCH LIMITATIONS
 
 
 
 
 
 
 
18.7.1
METHODOLOGY-RELATED LIMITATIONS
 
 
 
 
 
18.8
RISK ASSESSMENT
 
 
 
 
 
19
APPENDIX
 
 
 
 
 
426
 
19.1
DISCUSSION GUIDE
 
 
 
 
 
 
19.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
19.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
19.4
RELATED REPORTS
 
 
 
 
 
 
19.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
USD EXCHANGE RATES
 
 
 
 
 
 
TABLE 2
AI IN PROTEIN ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
AI IN PROTEIN ENGINEERING MARKET: ROLE IN ECOSYSTEM
 
 
 
 
 
 
TABLE 4
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET, BY OFFERING (2025)
 
 
 
 
 
 
TABLE 5
INDICATIVE PRICE FOR AI IN PROTEIN ENGINEERING MARKET, BY REGION (2025)
 
 
 
 
 
 
TABLE 6
AI IN PROTEIN ENGINEERING MARKET: KEY CONFERENCES, 2026–2027
 
 
 
 
 
 
TABLE 7
CASE 1: AI-GUIDED ENZYME OPTIMIZATION USING HISTORICAL EXPERIMENTAL DATA
 
 
 
 
 
 
TABLE 8
CASE 2: AI-GENERATED PROTEIN DESIGN FOR PRECISION GENE EDITING
 
 
 
 
 
 
TABLE 9
CASE 3: COMPUTATIONAL PROTEIN DESIGN FOR AI-DESIGNED PEPTIDE THERAPEUTIC
 
 
 
 
 
 
TABLE 10
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 11
JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
TABLE 12
AI IN PROTEIN ENGINEERING MARKET: KEY PATENTS/PATENT APPLICATIONS
 
 
 
 
 
 
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 16
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
REGULATORY SCENARIO OF NORTH AMERICA
 
 
 
 
 
 
TABLE 19
REGULATORY SCENARIO OF EUROPE
 
 
 
 
 
 
TABLE 20
REGULATORY SCENARIO OF ASIA PACIFIC
 
 
 
 
 
 
TABLE 21
REGULATORY SCENARIO OF LATIN AMERICA
 
 
 
 
 
 
TABLE 22
REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
 
 
 
 
 
 
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
 
 
 
 
 
 
TABLE 24
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
TABLE 25
UNMET NEEDS IN AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
TABLE 26
END USER EXPECTATIONS IN AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
TABLE 27
AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
AI IN PROTEIN ENGINEERING MARKET, FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
AI IN PROTEIN ENGINEERING MARKET, FOR SOFTWARE/PLATFORMS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
AI IN PROTEIN ENGINEERING MARKET, FOR NICHE POINT SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
AI IN PROTEIN ENGINEERING MARKET, FOR END-TO-END SOLUTIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
AI IN PROTEIN ENGINEERING MARKET, FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
AI IN PROTEIN ENGINEERING MARKET, FOR SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
AI IN PROTEIN ENGINEERING MARKET, FOR CONSULTING & ADVISORY SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
AI IN PROTEIN ENGINEERING MARKET, FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
AI IN PROTEIN ENGINEERING MARKET, FOR TRAINING & SUPPORT SERVICES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
AI IN PROTEIN ENGINEERING MARKET FOR MACHINE LEARNING & DEEP LEARNING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN LANGUAGE MODELS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
AI IN PROTEIN ENGINEERING MARKET FOR GENERATIVE AI, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
AI IN PROTEIN ENGINEERING MARKET FOR STRUCTURE-BASED AI, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
AI IN PROTEIN ENGINEERING MARKET FOR OTHER TOOLS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
AI IN PROTEIN ENGINEERING MARKET FOR THERAPEUTIC PROTEIN ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
AI IN PROTEIN ENGINEERING MARKET FOR MULTISPECIFIC & BISPECIFIC PROTEIN ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
AI IN PROTEIN ENGINEERING MARKET FOR CYTOKINE & GROWTH FACTOR ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN BINDER ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
AI IN PROTEIN ENGINEERING MARKET FOR OTHER NEXT-GENERATION BIOLOGICS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
AI IN PROTEIN ENGINEERING MARKET FOR MOLECULAR GLUES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
AI IN PROTEIN ENGINEERING MARKET FOR DATA GENERATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY AFFINITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY SPECIFICITY & CROSS-REACTIVITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DEVELOPABILITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
AI IN PROTEIN ENGINEERING MARKET FOR BISPECIFIC & MULTISPECIFIC ANTIBODY ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
AI IN PROTEIN ENGINEERING MARKET FOR OTHER ANTIBODY ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
AI IN PROTEIN ENGINEERING MARKET FOR ENZYME ENGINEERING, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
AI IN PROTEIN ENGINEERING MARKET FOR DE NOVO PROTEIN DESIGN, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN STABILITY & DEVELOPABILITY OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
AI IN PROTEIN ENGINEERING MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
AI IN PROTEIN ENGINEERING MARKET FOR ENZYMES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
AI IN PROTEIN ENGINEERING MARKET FOR CYTOKINES & GROWTH FACTORS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
AI IN PROTEIN ENGINEERING MARKET FOR PEPTIDES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
AI IN PROTEIN ENGINEERING MARKET FOR FUSION PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
AI IN PROTEIN ENGINEERING MARKET FOR MINIPROTEIN, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
AI IN PROTEIN ENGINEERING MARKET FOR OTHER PROTEINS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN DISCOVERY, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN DESIGN, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN OPTIMIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
AI IN PROTEIN ENGINEERING MARKET FOR PROTEIN CHARACTERIZATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
AI IN PROTEIN ENGINEERING MARKET FOR EXPERIMENTAL VALIDATION, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
AI IN PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
AI IN PROTEIN ENGINEERING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
AI IN PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
AI IN PROTEIN ENGINEERING MARKET FOR INDUSTRIAL BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
AI IN PROTEIN ENGINEERING MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
AI IN PROTEIN ENGINEERING MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
NORTH AMERICA AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
US: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
US: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
US: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
US: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
US: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
US: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
US: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
US: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
US: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
US: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
CANADA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
CANADA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
GERMANY: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
GERMANY: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
FRANCE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
FRANCE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
UK: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
UK: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
UK: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
UK: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
UK: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
UK: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
UK: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
UK: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
UK: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
UK: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
ITALY: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
ITALY: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
SPAIN: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
SPAIN: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
REST OF EUROPE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
CHINA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
CHINA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
JAPAN: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
JAPAN: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
INDIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
INDIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
AUSTRALIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
SOUTH KOREA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
REST OF ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
BRAZIL: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
BRAZIL: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
MEXICO: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
MEXICO: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
REST OF LATIN AMERICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
SAUDI ARABIA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
UAE: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
UAE: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
UAE: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
UAE: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
UAE: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
UAE: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
UAE: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
UAE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
UAE: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
UAE: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
OTHER GCC COUNTRIES: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
SOUTH AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY OFFERING, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SOFTWARE/PLATFORMS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 364
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 365
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY AI TOOL, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 366
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 367
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR NEXT-GENERATION BIOLOGICS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 368
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET FOR ANTIBODY DISCOVERY & OPTIMIZATION, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 369
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 370
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY PROTEIN ENGINEERING PROCESS, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 371
REST OF MIDDLE EAST & AFRICA: AI IN PROTEIN ENGINEERING MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 372
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN PROTEIN ENGINEERING MARKET, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 373
THE AI IN PROTEIN ENGINEERING MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 374
AI IN PROTEIN ENGINEERING MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 375
AI IN PROTEIN ENGINEERING MARKET: OFFERING FOOTPRINT
 
 
 
 
 
 
TABLE 376
AI IN PROTEIN ENGINEERING MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 377
AI IN PROTEIN ENGINEERING MARKET: AI TOOL FOOTPRINT
 
 
 
 
 
 
TABLE 378
AI IN PROTEIN ENGINEERING MARKET: END USER FOOTPRINT
 
 
 
 
 
 
TABLE 379
AI IN PROTEIN ENGINEERING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 380
AI IN PROTEIN ENGINEERING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
 
 
 
 
 
 
TABLE 381
AI IN PROTEIN ENGINEERING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY OFFERING
 
 
 
 
 
 
TABLE 382
AI IN PROTEIN ENGINEERING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 383
AI IN PROTEIN ENGINEERING MARKET: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 384
SCHRÖDINGER, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 385
SCHRÖDINGER, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 386
SCHRÖDINGER, INC.: PRODUCT ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 387
SCHRÖDINGER, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 388
XTALPI: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 389
XTALPI: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 390
XTALPI: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 391
DASSAULT SYSTÈMES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 392
DASSAULT SYSTÈMES: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 393
DASSAULT SYSTÈMES: PRODUCT LAUNCHES/ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 394
DASSAULT SYSTÈMES: DEALS, JANUARY 2023– SEPTEMBER 2026
 
 
 
 
 
 
TABLE 395
NVIDIA CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 396
NVIDIA CORPORATION: PRODUCTS /SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 397
NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 398
NVIDIA CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 399
GENERATE:BIOMEDICINES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 400
GENERATE:BIOMEDICINES: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 401
GENERATE:BIOMEDICINES: PRODUCT ENHANCEMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 402
GENERATE:BIOMEDICINES: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 403
ABSCI CORP.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 404
ABSCI CORP.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 405
ABSCI CORP.: DEALS, JANUARY 2023– SEPTEMBER 2026
 
 
 
 
 
 
TABLE 406
INSILICO MEDICINE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 407
INSILICO MEDICINE: PRODUCTS /SOLUTIONS OFFERED
 
 
 
 
 
 
TABLE 408
INSILICO MEDICINE: PRODUCT LAUNCHES/ENHANCEMENT, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 409
INSILICO MEDICINE: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 410
CRADLE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 411
CRADLE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 412
CRADLE: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 413
CRADLE: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 414
A-ALPHA BIO, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 415
A-ALPHA BIO, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 416
A-ALPHA BIO, INC.: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 417
A-ALPHA BIO, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 418
A-ALPHA BIO, INC.: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 419
ISOMORPHIC LABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 420
ISOMORPHIC LABS: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 421
ISOMORPHIC LABS: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 422
ISOMORPHIC LABS: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 423
CHAI DISCOVERY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 424
CHAI DISCOVERY: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 425
CHAI DISCOVERY: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 426
CHAI DISCOVERY: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 427
CHAI DISCOVERY: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 428
EVOLUTIONARYSCALE (BIOHUB): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 429
EVOLUTIONARYSCALE (BIOHUB): PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 430
EVOLUTIONARYSCALE (BIOHUB): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 431
EVOLUTIONARYSCALE (BIOHUB): DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 432
EVOLUTIONARYSCALE (BIOHUB): OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 433
PROFLUENT: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 434
PROFLUENT: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 435
PROFLUENT: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 436
PROFLUENT: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 437
BIGHAT BIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 438
BIGHAT BIO: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 439
BIGHAT BIO: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 440
BIGHAT BIO: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 441
LATENT LABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 442
LATENT LABS: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 443
LATENT LABS: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 444
LATENT LABS: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 445
LATENT LABS: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 446
BASECAMP RESEARCH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 447
BASECAMP RESEARCH: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 448
BASECAMP RESEARCH: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 449
BASECAMP RESEARCH: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 450
BASECAMP RESEARCH: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 451
NABLA BIO, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 452
NABLA BIO, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 453
NABLA BIO, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 454
NABLA BIO, INC.: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 455
EVOZYNE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 456
EVOZYNE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 457
EVOZYNE: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 458
EVOZYNE: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 459
LABGENIUS LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 460
LABGENIUS LIMITED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 461
LABGENIUS LIMITED: DEALS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 462
LABGENIUS LIMITED: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
 
 
 
 
 
 
TABLE 463
ARZEDA CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 464
MENTEN AI: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 465
PROTEINQURE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 466
OUTPACE BIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 467
AI PROTEINS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 468
MONODBIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 469
BIOMATTER INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 470
DIFFUSE BIO: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 471
RISK ASSESSMENT: AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
AI IN PROTEIN ENGINEERING MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 3
GLOBAL AI IN PROTEIN ENGINEERING MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN PROTEIN ENGINEERING MARKET, 2023–2026
 
 
 
 
 
 
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
FIGURE 6
HIGH-GROWTH SEGMENTS IN AI IN PROTEIN ENGINEERING MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN AI IN PROTEIN ENGINEERING MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 8
INCREASING R&D INVESTMENTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE GROWTH IN AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
FIGURE 9
SOFTWARE/PLATFORMS HELD MAJOR SHARE IN NORTH AMERICA IN 2025
 
 
 
 
 
 
FIGURE 10
INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 11
AI IN PROTEIN ENGINEERING MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 12
AI IN PROTEIN ENGINEERING MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 13
AI IN PROTEIN ENGINEERING MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 14
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 16
PATENT PUBLICATION TRENDS IN AI IN PROTEIN ENGINEERING MARKET, 2015–2026
 
 
 
 
 
 
FIGURE 17
JURISDICTION AND TOP APPLICANT ANALYSIS FOR AI IN PROTEIN ENGINEERING MARKET
 
 
 
 
 
 
FIGURE 18
TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN PROTEIN ENGINEERING MARKET (JANUARY 2015 TO JUNE 2026)
 
 
 
 
 
 
FIGURE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
 
 
 
 
 
 
FIGURE 20
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
 
 
FIGURE 21
NORTH AMERICA: AI IN PROTEIN ENGINEERING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 22
ASIA PACIFIC: AI IN PROTEIN ENGINEERING MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 23
AI IN PROTEIN ENGINEERING MARKET: REVENUE ANALYSIS OF KEY PLAYERS
 
 
 
 
 
 
FIGURE 24
AI IN PROTEIN ENGINEERING MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
 
 
 
 
 
 
FIGURE 25
AI IN PROTEIN ENGINEERING MARKET: BRAND COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 26
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 27
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 28
AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX (2025)
 
 
 
 
 
 
FIGURE 29
AI IN PROTEIN ENGINEERING MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 30
AI IN PROTEIN ENGINEERING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 31
SCHRÖDINGER, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 32
XTALPI: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 33
DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 34
NVIDIA CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 35
ABSCI CORP.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 36
INSILICO MEDICINE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 37
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 38
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 39
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
 
 
FIGURE 40
BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 41
TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 42
CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF AI IN PROTEIN ENGINEERING INDUSTRY
 
 
 
 
 
 
FIGURE 43
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 44
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

Methodology

This research study used extensive primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and Companies House documents. The secondary research aimed to gather and analyze information for a comprehensive, commercially focused study of the AI in protein engineering market, covering technical aspects and market dynamics. It also helped identify key players, market segments, industry trends, geographic markets, and significant market developments. Additionally, secondary research compiled a database of prominent industry leaders.

Primary Research

In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the AI in protein engineering market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, contract research organizations, academic and research institutes, and industrial biotechnology companies.

A breakdown of the primary respondents is provided below:

AI in Protein Engineering Market Size, and Share

*Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the AI in protein engineering market was determined by triangulating data using the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.

AI in Protein Engineering Market: Top-Down and Bottom-Up Approach

AI in Protein Engineering Market Top Down and Bottom Up Approach

Data Triangulation

The size of the AI in protein engineering market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:

  • Revenues for individual companies were gathered from public sources and databases.
  • Shares of leading players in the AI in protein engineering market were gathered from secondary sources to the extent available. In some cases, shares of AI in protein engineering businesses were estimated after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach & strength.
  • Individual shares or revenue estimates were validated through interviews with experts.
  • The total revenue in the AI in protein engineering market was determined by extrapolating the market share data of major companies.

Market Definition

The AI in protein engineering market comprises AI-powered software, platforms, and services used to discover, design, optimize, characterize, and validate proteins with desired structural and functional properties. It includes machine learning, deep learning, protein language models, generative AI, and structure-based AI applied to antibody discovery, enzyme engineering, de novo protein design, protein stability, next-generation biologics, and other protein-engineering workflows. The market serves pharmaceutical and biotechnology companies, CROs, academic institutions, and industrial biotechnology organizations.

Key Stakeholders

  • AI Protein Engineering Platform & Software Providers
  • Pharmaceutical & Biopharmaceutical Companies
  • Biotechnology Companies & Protein Engineering Startups
  • Contract Research Organizations (CROs)
  • Academic & Research Institutions/Universities
  • Protein Engineering & Medical Research Laboratories
  • Computational Biology & Bioinformatics Companies
  • AI/ML Technology & Cloud Computing Providers
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Research & Development (R&D) Organizations
  • Regulatory Agencies & Government Bodies
  • Clinical & Translational Research Organizations
  • Investors & Venture Capital Firms
  • Business Research & Consulting Service Providers

Report Objectives

  • To define, describe, and forecast the AI in protein engineering market based on offering, AI tool, application, protein type, protein engineering process, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall AI in protein engineering market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall AI in protein engineering market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.   

Available customizations:

With the provided market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

  • Company Information
  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific AI in protein engineering market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
  • Further breakdown of the Rest of Europe AI in protein engineering market into Russia, Austria, Finland, Sweden, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the AI in Protein Engineering Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in AI in Protein Engineering Market

DMCA.com Protection Status
popup img